Repro Med Systems Stock Investor Sentiment

KRMD Stock  USD 3.66  0.14  3.98%   
About 72 percent of all Repro Med's shareholders are curious in acquiring. The analysis of overall sentiment of trading Repro Med Systems stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Repro Med's historical and current headlines, can help investors time the market. In addition, many technical investors use Repro Med Systems stock news signals to limit their universe of possible portfolio assets.
  

Repro Med Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Repro Med can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at businesswire.com         
KORU Medical Systems to Participate in Piper Sandlers 36th Annual Healthcare Conference
businesswire News
few days ago at news.google.com         
KRMD stock touches 52-week high at 3.41 amid robust growth - Investing.com Australia
Google News at Macroaxis
few days ago at news.google.com         
KRMD stock touches 52-week high at 3.41 amid robust growth - Investing.com India
Google News at Macroaxis
over a week ago at simplywall.st         
KORU Medical Systems, Inc. Released Earnings Last Week And Analysts Lifted Their Price Target To US4...
Simply Wall St News at Macroaxis
over a week ago at insidermonkey.com         
KORU Medical Systems, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a week ago at thelincolnianonline.com         
Piper Sandler Issues Positive Forecast for KORU Medical Systems Stock Price
news
over a week ago at investing.com         
Koru Medical stock price target upgraded, rating held on Q3 report
Investing News at Macroaxis
over a week ago at gurufocus.com         
KORU Medical Systems Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth and ...
Gurufocus Stories at Macroaxis
over a week ago at investing.com         
Koru Medical Systems stock target increased, holds buy on strong quarter
Investing News at Macroaxis
over a week ago at businesswire.com         
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-...
businesswire News
over a week ago at zacks.com         
KORU Medical Systems Inc. Reports Q3 Loss, Tops Revenue Estimates
zacks News
over a week ago at seekingalpha.com         
KORU Medical Systems Non-GAAP EPS of -0.03 beats by 0.01, revenue of 8.2M beats by 0.49M
seekingalpha News
over a week ago at businesswire.com         
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-...
businesswire News
over a week ago at businesswire.com         
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-...
businesswire News
over a week ago at businesswire.com         
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-...
businesswire News
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.

Repro Med Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Linda Tharby of 19681 shares of Repro Med at 2.09 subject to Rule 16b-3
09/20/2024
2
Acquisition by Manko Joseph M. Jr. of 5454 shares of Repro Med subject to Rule 16b-3
09/30/2024
3
Acquisition by Cascella Robert of 5454 shares of Repro Med at 2.75 subject to Rule 16b-3
10/01/2024
4
The past five years for KORU Medical Systems investors has not been profitable
10/03/2024
5
Albion Financial Group UT Reduces Stake in KORU Medical Systems, Inc.
10/11/2024
6
Teleflex Surpasses Q3 Earnings Estimates
10/31/2024
7
Disposition of 721781 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3
11/08/2024
8
InspireMD, Inc. Reports Q3 Loss, Tops Revenue Estimates
11/12/2024
9
KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth Raises Full Year 2024 Guidance
11/13/2024
10
KORU Medical Systems Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth and ...
11/14/2024
11
KORU Medical Systems to Participate in Piper Sandlers 36th Annual Healthcare Conference
11/25/2024

Complementary Tools for Repro Stock analysis

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital